News for electroCore, Inc. (ECOR)

On May 12, 2025, Thomas Errico, a Director at electroCore Inc (ECOR), purchased 10,000 shares of the company, as reported in the SEC Filing. Following this tran

Release Date: May 07, 2025For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points electroCore Inc (

Refinitiv StreetEvents Event TranscriptE D I T E D V E R S I O NECOR.OQ - electroCore, Inc.Q1 2025 electroCore, Inc. Earnings CallMay 07, 2025 / 08:30PM GMT =

Texas-based Asset Entities Inc. (ASST) is up over 54 percent in Thursday's pre-market trading. The following are some of the other stocks making big moves in Thursday's pre-market trading.

Discover how electroCore's Q1 2025 earnings reveal 23% revenue growth, boosted by the NeuroMetrix acquisition and Truvaga's international expansion.

electroCore, Inc. (NASDAQ:ECOR) Q1 2025 Earnings Conference Call May 7, 2025 4:30 PM ETCompany ParticipantsDan Goldberger - Chief Executive Officer and...

electroCore (ECOR) delivered earnings and revenue surprises of 16.07% and 1.12%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

**media[618036]**

**media[612705]**

ROCKAWAY, N.J., May 01, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. ( ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today th

ROCKAWAY, N.J., April 30, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. ( ECOR), a commercial-stage bioelectronic technology company, announced today that it wil

**media[610212]**

ElectroCore, Inc. (ECOR) has unveiled promising findings at the 2025 International Brain Injury Association World Congress, showcasing the efficacy of their gam

ROCKAWAY, N.J., April 17, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. ( ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today

ROCKAWAY, N.J., April 16, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. ( ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today

ROCKAWAY, N.J., April 03, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. ( ECOR), a commercial-stage bioelectronic medicine and wellness company, has been recogni

On March 17, 2025, Thomas Errico, a Director at electroCore Inc (ECOR), purchased 6,000 shares of the company. Following this transaction, the insider now owns

Revenue: $25.2 million for 2024, up 57% from 2023.Fourth Quarter Revenue: $7 million, a 36% increase over Q4 2023.Gross Margin: 85% for 2024, compared to 83% i

Mar 12, 2025 / 09:30PM GMTOperator Greetings and welcome to the electroCore fourth-quarter and full-year 2024 earnings conference call. As part of our ongoing e